ARCA Biotechnology Companies By Shares Outstanding

Shares Outstanding
Shares OutstandingEfficiencyMarket RiskExp Return
1GILD Gilead Sciences
1.25 B
 0.22 
 1.56 
 0.34 
2GMAB Genmab AS
636.59 M
(0.01)
 2.80 
(0.04)
3AMGN Amgen Inc
537.2 M
 0.20 
 1.50 
 0.30 
4MRNA Moderna
386.62 M
(0.05)
 5.37 
(0.24)
5EXEL Exelixis
279.88 M
 0.07 
 2.41 
 0.17 
6VRTX Vertex Pharmaceuticals
256.79 M
 0.24 
 1.50 
 0.36 
7BNTX BioNTech SE
239.97 M
(0.07)
 3.26 
(0.23)
8INCY Incyte
193.52 M
(0.08)
 2.20 
(0.17)
9BMRN Biomarin Pharmaceutical
190.78 M
 0.10 
 1.64 
 0.16 
10EXAS EXACT Sciences
185.76 M
(0.15)
 2.53 
(0.38)
11ACAD ACADIA Pharmaceuticals
166.79 M
 0.03 
 2.80 
 0.08 
12ALKS Alkermes Plc
162.61 M
 0.13 
 1.89 
 0.25 
13ILMN Illumina
158.4 M
(0.29)
 2.74 
(0.80)
14BRKR Bruker
151.7 M
(0.19)
 2.59 
(0.50)
15BIIB Biogen Inc
146.38 M
(0.06)
 1.76 
(0.11)
16NTRA Natera Inc
135.19 M
(0.04)
 2.80 
(0.12)
17ALNY Alnylam Pharmaceuticals
129.43 M
 0.08 
 3.02 
 0.26 
18HALO Halozyme Therapeutics
123.53 M
 0.33 
 1.46 
 0.48 
19REGN Regeneron Pharmaceuticals
107.51 M
(0.07)
 2.06 
(0.14)
20ITCI Intracellular Th
106.52 M
 0.18 
 4.76 
 0.84 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.